|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | First Nations Health Networks:A Collaborative System Approach to Health Transfer显示文摘 | JOSEé LAVOIE | 2008 | Healthcare Policy2008,4,2: | 1 |
| 2 | Small World Patterns in Food Webs显示文摘 | JOSE M. MONTOYA RICARD V. SOLé | 2002 | Journal of Theoretical Biology2002,,3: | 1 |
| 3 | Independent control of sol molar mass and gel content in acrylate polymer/latexes显示文摘 | Julien Chauvet José M. Asua Jose R. Leiza | 2005 | Polymer2005,,23: | 1 |
| 4 | Design of two-dimensional zero reference codes by means of a global optimization method显示文摘 | Jose Saez-LANDETE José ALONSO Eusebio BERNABEU | 2005 | Optics Express2005,13,11: | 1 |
| 5 | FUNGAL PERITONITIS IN PERITONEAL DIALYSIS PATIENTS: SUCCESSFUL PROPHYLAXIS WITH FLUCONAZOLE, AS DEMONSTRATED BY PROSPECTIVERANDOMIZED CONTROL TRIAL显示文摘 | César Restrepo Jose Chacon Gilberto Manjarres | 2010 | Peritoneal Dialysis International2010,,6: | 1 |
| 6 | Model CANVAS: Its Application for the Promotion of Regional Economies Under the Case Study of Buffalo Milk Cheese显示文摘 | Martine Joseé Pozo Regina Durán | 2018 | Journal of Modern Accounting and Auditing2018,14,4: | 0 |
| 7 | Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications显示文摘 | Pablo Bellot Rubén Francés Jose Such | 2012 | Liver Int2012,,1: | 4 |
| 8 | Suitability of enzyme activities for the monitoring of soil quality improvement in organic agricultural systems显示文摘 | Roberto García-Ruiz Victoria Ochoa M. Belén Hinojosa Jose Antonio Carreira | 2008 | Soil Biology and Biochemistry2008,,9: | 2 |
| 9 | Effects of biochar and greenwaste compost amendments on mobility, bioavailability and toxicity of inorganic and organic contaminants in a multi-element polluted soil显示文摘 | Luke Beesley Eduardo Moreno-Jiménez Jose L. Gomez-Eyles | 2010 | Environmental Pollution2010,,6: | 2 |
| 10 | State of the Art of Finite Control Set Model Predictive Controlin Power Electronics显示文摘 | Jose Rodriguez Marian P Kazmierkowski JoséR Espinoza | 2013 | Industrial Electronics IEEE Trans-actions on2013,9,2: | 1 |
| 11 | Testbeds for ubiquitous robotics:A survey显示文摘 | Jiménez-González Adrián Martinez-de Dios Jose Ramiro | | 0,,12: | 1 |
| 12 | Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain显示文摘 | Fiona Doetsch Isabelle Caillé Daniel A. Lim Jose Manuel García-Verdugo Arturo Alvarez-Buylla | 1999 | Cell1999,,6: | 1 |
| 13 | Antibodies in the treatment of aplastic anemai显示文摘 | David Gómez-Almaguer Jose Carlos Jaime-Pérez Guillermo J | 2012 | Arch Immunol2012,60,: | 1 |
| 14 | Biodesulphurisation of coal by microorganisms isolated from the coal itself显示文摘 | Angel Aller Olegario Martínez Joseé A de Linaje | | 0,,01: | 1 |
| 15 | Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 Update显示文摘 | Jose M. Miro Peter Stock Elina Teicher Jean-Charles Duclos-Vallée Norah Terrault Antoni Rimola | 2014 | Journal of Hepatology2014,,: | 1 |
| 16 | Spectral calibration and atmospheric correction of ultra-fine spectral and spatial resolution remote sensing data. Application to CASI-1500 data显示文摘 | Luis Guanter Víctor Estellés Jose Moreno | 2006 | Remote Sensing of Environment2006,,1: | 1 |
| 17 | Digital ants as the best cicerones for museum visitors显示文摘 | Javier Jaén Jose Antonio Mocholí Alejandro Catalá Elena Navarro | 2009 | Applied Soft Computing Journal2009,,1: | 1 |
| 18 | How does competition affect bank risk-taking?显示文摘 | Gabriel Jiménez Jose A. Lopez Jesús Saurina | 2013 | Journal of Financial Stability2013,,2: | 1 |
| 19 | Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis显示文摘Hepatitis B virus (HBV) is a very common infection worldwide. Its reactivation in patients receiving immunosuppression has been widely described as being associated with significant morbidity and mortality unless anti-viral prophylaxis is administered. Treatment in inflammatory bowel disease (IBD) patients has changed in recent years and immunosuppression and biological therapies are now used more frequently than before. Although current studies have reported an incidence of hepatitis B in inflammatory bowel disease patients similar to that in the general population, associated liver damage remains an important concern in this setting. Liver dysfunction may manifest in several ways, from a subtle change in serum aminotransferase levels to fulminant liver failure and death. Patients undergoing double immunosuppression are at a higher risk, and reactivation usually occurs after more than one year of treatment. As preventive measures, all IBD patients should be screened for HBV markers at diagnosis and those who are positive for the hepatitis B surface antigen should receive antiviral prophylaxis before undergoing immunosuppression in order to avoid HBV reactivation. Tenofovir/entecavir are preferred to lamivudine as nucleos(t)ide analogues due to their better resistance profile. In patients with occult or resolved HBV, viral reactivation does not appear to be a relevant issue and regular DNA determination is recommended during immunosuppression therapy. Consensus guidelines on this topic have been published in recent years. The prevention and management of HBV infection in IBD patients is addressed in this review in order to address practical | Pilar López-Serrano Jose Lázaro Pérez-Calle Maria Dolores Sánchez-Tembleque | 2013 | World Journal of Gastroenterology2013,19,9: | 12 |
| 20 | Prevalence of occult hepatitis B virus infection显示文摘Occult hepatitis B virus(HBV) infection(OBI) is characterized by the persistence of HBV DNA in the liver tissue in individuals negative for the HBV surface antigen.The prevalence of OBI is quite variable depending on the level of endemic disease in different parts of the world,the different assays utilized in the studies,and the different populations studied.Many studies have been carried out on OBI prevalence in different areas of the world and categories of individuals.The studies show that OBI prevalence seems to be higher among subjects at high risk for HBV infection and with liver disease than among individuals at low risk of infection and without liver disease. | Maria Luisa Gutiérrez-García Conrado M Fernandez-Rodriguez Jose Luis Lledo-Navarro Ingrid Buhigas-Garcia | 2011 | World Journal of Gastroenterology2011,17,12: | 10 |